Nanomaterial scaffolds to regenerate musculoskeletal tissue: Signals from within for neovessel formation

Zuyong Wang, Feng Wen, Poon Nian Lim, Qinyuan Zhang, Toshiisa Konishi, Dong Wang, Swee Hin Teoh, Eng San Thian

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Current treatments for musculoskeletal disease and injury are restricted with the usage of autografts and allografts. Tissue engineering that applies the principles of biology and engineering to develop functional substitutes has potential promise of therapeutic regeneration for musculoskeletal tissues. However, engineering sizable tissues needs a vascular network to supply cells with nutrients, oxygen and signals after implantation. For this purpose, recent developments on therapeutic nanomaterials have been explored in delivering different vessel-inductive growth factors, small biomolecules and ions for scalable engineering into vascularizable scaffolds. Here, we provide an overview on the current efforts, and propose future perspectives for precise regulation on vascularization processes and musculoskeletal tissue functionality.

Original languageEnglish
JournalDrug Discovery Today
DOIs
Publication statusAccepted/In press - 2017

Fingerprint

Nanostructures
Tissue Engineering
Musculoskeletal Diseases
Autografts
Allografts
Blood Vessels
Regeneration
Intercellular Signaling Peptides and Proteins
Ions
Oxygen
Food
Wounds and Injuries
Therapeutics

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Nanomaterial scaffolds to regenerate musculoskeletal tissue : Signals from within for neovessel formation. / Wang, Zuyong; Wen, Feng; Lim, Poon Nian; Zhang, Qinyuan; Konishi, Toshiisa; Wang, Dong; Teoh, Swee Hin; Thian, Eng San.

In: Drug Discovery Today, 2017.

Research output: Contribution to journalArticle

Wang, Zuyong ; Wen, Feng ; Lim, Poon Nian ; Zhang, Qinyuan ; Konishi, Toshiisa ; Wang, Dong ; Teoh, Swee Hin ; Thian, Eng San. / Nanomaterial scaffolds to regenerate musculoskeletal tissue : Signals from within for neovessel formation. In: Drug Discovery Today. 2017.
@article{97059d3d00bd45d7b42dee2e5fba09ab,
title = "Nanomaterial scaffolds to regenerate musculoskeletal tissue: Signals from within for neovessel formation",
abstract = "Current treatments for musculoskeletal disease and injury are restricted with the usage of autografts and allografts. Tissue engineering that applies the principles of biology and engineering to develop functional substitutes has potential promise of therapeutic regeneration for musculoskeletal tissues. However, engineering sizable tissues needs a vascular network to supply cells with nutrients, oxygen and signals after implantation. For this purpose, recent developments on therapeutic nanomaterials have been explored in delivering different vessel-inductive growth factors, small biomolecules and ions for scalable engineering into vascularizable scaffolds. Here, we provide an overview on the current efforts, and propose future perspectives for precise regulation on vascularization processes and musculoskeletal tissue functionality.",
author = "Zuyong Wang and Feng Wen and Lim, {Poon Nian} and Qinyuan Zhang and Toshiisa Konishi and Dong Wang and Teoh, {Swee Hin} and Thian, {Eng San}",
year = "2017",
doi = "10.1016/j.drudis.2017.03.010",
language = "English",
journal = "Drug Discovery Today",
issn = "1359-6446",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Nanomaterial scaffolds to regenerate musculoskeletal tissue

T2 - Signals from within for neovessel formation

AU - Wang, Zuyong

AU - Wen, Feng

AU - Lim, Poon Nian

AU - Zhang, Qinyuan

AU - Konishi, Toshiisa

AU - Wang, Dong

AU - Teoh, Swee Hin

AU - Thian, Eng San

PY - 2017

Y1 - 2017

N2 - Current treatments for musculoskeletal disease and injury are restricted with the usage of autografts and allografts. Tissue engineering that applies the principles of biology and engineering to develop functional substitutes has potential promise of therapeutic regeneration for musculoskeletal tissues. However, engineering sizable tissues needs a vascular network to supply cells with nutrients, oxygen and signals after implantation. For this purpose, recent developments on therapeutic nanomaterials have been explored in delivering different vessel-inductive growth factors, small biomolecules and ions for scalable engineering into vascularizable scaffolds. Here, we provide an overview on the current efforts, and propose future perspectives for precise regulation on vascularization processes and musculoskeletal tissue functionality.

AB - Current treatments for musculoskeletal disease and injury are restricted with the usage of autografts and allografts. Tissue engineering that applies the principles of biology and engineering to develop functional substitutes has potential promise of therapeutic regeneration for musculoskeletal tissues. However, engineering sizable tissues needs a vascular network to supply cells with nutrients, oxygen and signals after implantation. For this purpose, recent developments on therapeutic nanomaterials have been explored in delivering different vessel-inductive growth factors, small biomolecules and ions for scalable engineering into vascularizable scaffolds. Here, we provide an overview on the current efforts, and propose future perspectives for precise regulation on vascularization processes and musculoskeletal tissue functionality.

UR - http://www.scopus.com/inward/record.url?scp=85017332027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017332027&partnerID=8YFLogxK

U2 - 10.1016/j.drudis.2017.03.010

DO - 10.1016/j.drudis.2017.03.010

M3 - Article

C2 - 28363083

AN - SCOPUS:85017332027

JO - Drug Discovery Today

JF - Drug Discovery Today

SN - 1359-6446

ER -